Skip to content

LiverTracer „Device for identification of liver dysfunction“

LiverTracer „Device for identification of liver dysfunction“ - LiverTracer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00016525
Enrollment
80
Registered
2019-01-21
Start date
2019-02-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K74.6

Interventions

Group 1: Patients without cirrhosis After study inclusion we perform measurements of metabolic compounds of breathing air with a MOX gas sensor. This will serve as a reference for study arms 2 to 4. T

Sponsors

Universitätsklinikum Jena
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis of liver cirrhosis according to Imaging, clinical criteria or histology (except for control Group without cirrhosis), Age > 18 yrs, written informed consent

Exclusion criteria

Exclusion criteria: • known malignancy • mechanical biliary obstruction • uncontrolled Diabetes mellitus • severe respiratory disease (pneumonia, COPD GOLD =III, Asthma bronchiale) • chronic kidney injury KDIGO =3 • congestive heart failure NYHA =3 • symptomatic coronary heart disease • peripheral arterial occlusive disease Fontaine =IIa

Design outcomes

Primary

MeasureTime frame
Death or LTX (Liver transplantation) at 12 weeks

Secondary

MeasureTime frame
New decompensation during 12 weeks New ACLF (Acute-on-chronic liver failure) according to EASL-CLIF Criteria during 12 weeks

Countries

Germany

Contacts

Public ContactPaul Horn

Klinik für Innere Medizin IV Universitätsklinikum Jena

paul.horn@med.uni-jena.de036419324640

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026